Expanded Indication for Recombinant Human Bone Morphogenetic Protein 2

スポンサーリンク

概要

論文の詳細を見る
2011-10-01

著者

関連論文

Complications and Concerns With Osteobiologics for Spine Fusion in Clinical Practice
The Minimum Clinically Important Difference in Scoliosis Research Society-22 Appearance, Activity, and Pain Domains After Surgical Correction of Adolescent Idiopathic Scoliosis
Off-Label Use of Bone Morphogenetic Proteins in the United States Using Administrative Data
National Revision Burden for Lumbar Total Disc Replacement in the United States : Epidemiologic and Economic Perspectives
Effect of Nucleus Replacement Device Properties on Lumbar Spine Mechanics
Health-Related Quality of Life Improvements in Patients Undergoing Lumbar Spinal Fusion as a Revision Surgery
Clinical Outcomes After Posterolateral Lumbar Fusion in Workers' Compensation Patients : A Case-Control Study
Patient Satisfaction After Surgical Correction of Adolescent Idiopathic Scoliosis
Risk-Benefit Assessment of Surgery for Adult Scoliosis : An Analysis Based on Patient Age
Predicting SF-6D Utility Scores From the Neck Disability Index and Numeric Rating Scales for Neck and Arm Pain
Complications in the Surgical Treatment of 19,360 Cases of Pediatric Scoliosis : A Review of the Scoliosis Research Society Morbidity and Mortality Database
Does Fusion Status Correlate with Patient Outcomes in Lumbar Spinal Fusion?
Expanded Indication for Recombinant Human Bone Morphogenetic Protein 2
The Discriminative Properties of the SF-6D Compared With the SF-36 and ODI
The Cost Effectiveness of Single-Level Instrumented Posterolateral Lumbar Fusion at 5 Years After Surgery

もっと見る

スポンサーリンク